Cleopatra Hospital Co.
Industry Group: Healthcare
Country/Region: Egypt
Identifier: CAI:CLHO
Cleopatra Hospital Co is a private hospital in Egypt. The company provides health and medical services, as well as the medical care of inpatients. Its operating segment based on hospitals includes Cleopatra Hospital Company, Cairo Specialised Hospital, Nile Badrawi Hospital, Al Shorouk Hospital, CHG for Medical Services, CHG Pharma for pharmacy management, CHG for Hospitals, Queens Hospitals and Al Kateb Hospitals. It generates maximum revenue from the Cleopatra Hospital Company segment. The company derives revenue from Accommodation and medical supervision, Surgeries, Outpatient clinics, Laboratories, Cardiac catheterization, Service charges, Radiology, Emergency, Oncology center, Pharmacy, Dentistry, Physiotherapy, Endoscopy, Cardiac tests, and Other services.
ESG Risk Rating
Ranking
Industry Group (1st = lowest risk)
Healthcare 464 out of 588
Universe
Global Universe 11251 out of 15104
What are the ESG Risk Ratings?
Notice: The information is provided as is, for informational, non-commercial purposes only, does not constitute investment advice and is subject to conditions available in our Legal Disclaimer. They are not directed to, or intended for distribution to or use by India-based clients or users and their distribution to Indian resident individuals or entities is not permitted. Usage of this information is not permitted in any way, unless otherwise agreed in writing. By way of exception, usage of this information is permitted to the non-India based rated subjects, limited to a single reference to the score on the rated subject’s sustainability webpage or CSR report, mentioning Sustainalytics as a source. For referencing Sustainalytics please consult the Company Guide.
Industry Comparison
| Company | ESG Risk Rating | Industry Rank |
|---|---|---|
| Medical Facilities Corp. |
29.3
Medium
|
387 out of 588 |
| Hospital Mater Dei SA |
31.1
High
|
444 out of 588 |
| Cleopatra Hospital Co. |
31.6
High
|
464 out of 588 |
| biote Corp. |
32.3
High
|
487 out of 588 |
| SUNWELS Co., Ltd. |
35.8
High
|
568 out of 588 |
For corporate professionals interested in direct competitor insights
Sustainalytics' Peer Performance Insights gives an in-depth analysis of your company's ESG strengths and weaknesses compared to your competitors and industry performance. These insights can be used to identify areas of ESG improvement to help inform future management decisions that align with your organization's sustainability goals.
Our Approach to Calculating ESG Risk
The ESG Risk Ratings measure a company's exposure to industry-specific material ESG risks and how well a company is managing those risks.
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues. Our exposure score takes into consideration subindustry and company-specific factors such as its business model.
Management
Management refers to how well a company is managing its relevant ESG issues. Our management score assesses the robustness of a company's ESG programs, practices and policies.